OneSource Specialty Pharma reports consolidated net loss of Rs 88.70 crore in the December 2025 quarter
(24 Jan 2026)

Back
Net Loss of OneSource Specialty Pharma reported to Rs 88.70 crore in the quarter ended December 2025 as against net loss of Rs 68.85 crore during the previous quarter ended December 2024. Sales declined 26.04% to Rs 290.34 crore in the quarter ended December 2025 as against Rs 392.56 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales290.34392.56 -26
OPM %5.9736.14 -
PBDT-16.28102.78 PL
PBT-85.9234.02 PL
NP-88.70-68.85 -29

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew